GLIS3 Antikörper (N-Term)
Kurzübersicht für GLIS3 Antikörper (N-Term) (ABIN925940)
Target
Alle GLIS3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Hund, Maus, Ratte (Rattus)
-
Immunogen
- GLIS3 antibody was raised in rabbit using the N terminal of GLIS3 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
GLIS3 Blocking Peptide, (ABIN5613781), is also available for use as a blocking control in assays to test for specificity of this GLIS3 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- GLIS3 (GLIS Family Zinc Finger 3 (GLIS3))
-
Andere Bezeichnung
- GLIS3
-
Hintergrund
- GLIS3 is a member of the GLI-similar zinc finger protein family and has five C2H2-type zinc finger domains. GLIS3 functions as both a repressor and activator of transcription and is specifically involved in the development of pancreatic beta cells, the thyroid, eye, liver and kidney. Mutations in this gene have been associated with neonatal diabetes and congenital hypothyroidism (NDH). Synonyms: Polyclonal GLIS3 antibody, Anti-GLIS3 antibody, GLIS family zinc finger 3 antibody.
Target
-